Latest Insider Transactions at Intrepid Potash, Inc. (IPI)
This section provides a real-time view of insider transactions for Intrepid Potash, Inc. (IPI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Intrepid Potash, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Intrepid Potash, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 19
2024
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,384
-0.35%
|
$102,296
$19.35 P/Share
|
Mar 17
2024
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
6,722
-1.3%
|
$127,718
$19.37 P/Share
|
Mar 17
2024
|
Matthew D Preston CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,590
-3.5%
|
$30,210
$19.37 P/Share
|
Mar 17
2024
|
Christina Sheehan General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-2.1%
|
$9,823
$19.37 P/Share
|
Mar 15
2024
|
Matthew D Preston CFO |
BUY
Grant, award, or other acquisition
|
Direct |
21,560
+32.2%
|
-
|
Mar 15
2024
|
Christina Sheehan General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
16,169
+39.64%
|
-
|
Mar 12
2024
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,247
-0.47%
|
$144,940
$20.07 P/Share
|
Mar 11
2024
|
Matthew D Preston CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.75%
|
$3,600
$20.25 P/Share
|
Mar 11
2024
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,000
-0.71%
|
$220,000
$20.22 P/Share
|
Mar 11
2024
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
4,616
-0.89%
|
$92,320
$20.25 P/Share
|
Mar 08
2024
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
63,372
-1.98%
|
$1,267,440
$20.78 P/Share
|
Dec 15
2023
|
Matthew D Preston CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-1.59%
|
$8,901
$23.33 P/Share
|
Jun 30
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
6,178
-1.17%
|
$135,916
$22.69 P/Share
|
Jun 08
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
7,147
-1.34%
|
$157,234
$22.27 P/Share
|
May 23
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,300
-1.79%
|
$586,000
$20.08 P/Share
|
May 22
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
41,858
-1.25%
|
$837,160
$20.22 P/Share
|
May 19
2023
|
Mary E Mc Bride Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,343
+20.21%
|
-
|
May 19
2023
|
Barth E Whitham Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,854
+10.3%
|
-
|
May 19
2023
|
William M Zisch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,343
+43.37%
|
-
|
May 19
2023
|
Chris A. Elliott Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,343
+9.8%
|
-
|
May 19
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
43,842
-2.55%
|
$832,998
$19.69 P/Share
|
May 19
2023
|
Lori A Lancaster Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,343
+33.52%
|
-
|
Mar 31
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
24,550
-4.4%
|
$662,850
$27.6 P/Share
|
Mar 17
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
117,987
+10.04%
|
-
|
Mar 17
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
2,272
-0.51%
|
$59,072
$26.05 P/Share
|
Mar 17
2023
|
Matthew D Preston CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,757
+39.23%
|
-
|
Mar 17
2023
|
Matthew D Preston CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
712
-7.6%
|
$18,512
$26.05 P/Share
|
Mar 17
2023
|
Christina Sheehan General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
7,878
+48.25%
|
-
|
Mar 17
2023
|
Christina Sheehan General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
75
-11.61%
|
$1,950
$26.05 P/Share
|
Mar 11
2023
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
4,473
-1.0%
|
$129,717
$29.03 P/Share
|
Mar 11
2023
|
Matthew D Preston CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-1.88%
|
$5,191
$29.03 P/Share
|
Dec 23
2022
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
5,404
-1.19%
|
$151,312
$28.9 P/Share
|
Dec 15
2022
|
Matthew D Preston CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-3.9%
|
$11,610
$30.79 P/Share
|
Dec 15
2022
|
Edward Brian Stone President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
595
-3.01%
|
$17,850
$30.79 P/Share
|
Jun 30
2022
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
114
-0.03%
|
$5,130
$45.29 P/Share
|
Jun 08
2022
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
7,146
-1.56%
|
$428,760
$60.57 P/Share
|
May 25
2022
|
Matthew D Preston CFO |
SELL
Open market or private sale
|
Direct |
6,136
-38.19%
|
$392,704
$64.74 P/Share
|
May 25
2022
|
Matthew D Preston CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,018
+5.96%
|
$10,180
$10.3 P/Share
|
May 19
2022
|
William M Zisch Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,327
+50.0%
|
-
|
May 19
2022
|
Chris A. Elliott Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,327
+3.59%
|
-
|
May 19
2022
|
Lori A Lancaster Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,327
+23.7%
|
-
|
May 19
2022
|
Mary E Mc Bride Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,327
+9.39%
|
-
|
May 19
2022
|
Barth E Whitham Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,327
+3.43%
|
-
|
Apr 19
2022
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
6,727
-1.44%
|
$787,059
$117.8 P/Share
|
Apr 12
2022
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
2,979
-0.63%
|
$321,732
$108.2 P/Share
|
Mar 31
2022
|
Robert P Jornayvaz Iii > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
17,363
-3.57%
|
-
|
Mar 31
2022
|
Robert P Jornayvaz Iii > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
31,506
+6.08%
|
-
|
Mar 24
2022
|
Clearway Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-1.47%
|
$1,840,000
$92.5 P/Share
|
Mar 23
2022
|
Clearway Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-1.45%
|
$1,800,000
$90.0 P/Share
|
Mar 18
2022
|
Robert E Baldridge SVP - New Mexico |
SELL
Open market or private sale
|
Direct |
16,039
-81.98%
|
$1,026,496
$64.89 P/Share
|